According to a study published on December 30, 2025, in Science Bulletin by a team led by Shanxi University physicist Xiaolong Su, the breakthrough overcomes a longstanding technical barrier by allowing adjustable, deterministic quantum teleportation without relying on a one-at-a-time process.
Overcoming Single-Channel Limitations in Continuous-Variable Systems
Traditional continuous-variable experiments typically handle quantum state transfers as a one-at-a-time process. According to the Shanxi University research team, scientists previously teleported just a single sideband qumode—essentially one distinct frequency channel riding on an optical field. Real communication systems require the ability to send many channels in parallel rather than taking turns, creating a stubborn hurdle for scaling quantum networks. To solve this, the researchers proposed and demonstrated controllable, deterministic continuous-variable quantum teleportation of multiple sideband qumodes simultaneously, as detailed in Science Bulletin. The approach hinges on carefully tuning the phases of two classical communication channels while selecting different adjustable frequencies, enabling the team to teleport up to five sideband qumodes within a 24 MHz bandwidth.
Scaling Bandwidth to 100 Channels Using Spatial Light Modulators
Expanding on the parallel transmission of quantum data, researchers have also demonstrated broader network scaling. According to findings published on August 20 in Physical Review Letters by a team including East China Normal University physics professor Jietai Jing, scientists scaled quantum teleportation up to 100 channels. This technique encodes a programmable, reconfigurable computer-generated hologram onto a spatial light modulator. The modulator passes a laser beam through the hologram to create a 10-by-10 grid pattern of distinct spatial modes functioning as pixels. Jietai Jing noted that a large quantum network requires many quantum channels to be generated, matched, and manipulated simultaneously, pointing out that the architecture contributes directly to high-capacity quantum communication.
Fidelities and Practical Implications for Quantum Networks
In the Shanxi University experiments, the teleported outputs reached fidelities of about 70%, with all tested channels surpassing the non-cloning limit. This benchmark marks the boundary between genuine quantum teleportation and results that could be replicated by purely classical strategies. By using phase control, researchers can choose how many qumodes are teleported in a given run rather than being locked into a fixed number. According to the Science Bulletin study, this combination provides a practical route for scaling up entanglement-based links. Packing more quantum information into the same physical setup allows quantum computers to connect as more powerful processors and links quantum sensors into high-precision arrays, all without needing a separate teleportation apparatus for every individual channel.
Keep reading
- Using Smartphones for Accurate Cataract Screening and Referral
- Best Samsung Galaxy S23 Chargers & Headphones Accessories
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)